Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth

Journal of Molecular Medicine

Volumn 84, Issue 2, 2006, Pages 126-131

  Flavell, David M ^a,e   Wootton, Peter T E ^a   Myerson, Saul G ^b   World, Michael J ^c   Pennell, Dudley J ^d   Humphries, Steve E ^a   Talmud, Philippa J ^a   Montgomery, Hugh E ^a,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f Institute for Human Health and Performance   (United Kingdom)

Author keywords

Exercise; Fatty acids; Genetics; Left ventricular hypertrophy; LPL; Metabolism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SERINE; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE VARIABILITY; CATABOLISM; CONTROLLED STUDY; EXERCISE; GENE; GENETIC VARIABILITY; GENOTYPE; HEART DEVELOPMENT; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PREDICTOR VARIABLE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; EXERCISE; GENETIC VARIATION; HEART VENTRICLES; HUMANS; LIPOPROTEIN LIPASE; LOSARTAN; MALE; MILITARY PERSONNEL; REFERENCE VALUES; VARIATION (GENETICS);

EID: 32044457362     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0002-8     Document Type: Article

References (41)

1. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470-479
2. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP (1988) Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 108:7-13
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352
4. Sack MN, Harrington LS, Jonassen AK, Mjos OD, Yellon DM (2000) Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats. Cardiovasc Drugs Ther 14:31-39
5. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD (1994) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267:H742-H750
6. Fatkin D, Graham RM (2002) Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82:945-980
7. Enerback S, Gimble JM (1993) Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1169:107-125
8. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A (1994) Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb 14:1445-1451
9. Merkel M, Eckel RH, Goldberg IJ (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997-2006
10. Masuzaki H, Jingami H, Matsuoka N et al (1996) Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circ Res 78:8-14
11. Sambandam N, Chen X, Cam MC, Rodrigues B (1997) Cardiac lipoprotein lipase in the spontaneously hypertensive rat. Cardiovasc Res 33:460-468
12. Vaziri ND, Liang K, Barton CH (1999) Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression. Biochim Biophys Acta 1436:577-584
13. Zhang H, Henderson H, Gagne SE et al (1996) Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302:159-166
14. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG (1999) Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901-2907
15. Wu DA, Bu X, Warden CH et al (1996) Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest 97:2111-2118
16. Allayee H, de Bruin TW, Michelle DK et al (2001) Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38:773-778
17. Yang W, Huang J, Ge D et al (2004) Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees. Hum Genet 115:8-12
18. Clee SM, Loubser O, Collins J, Kastelein JJ, Hayden MR (2001) The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin Genet 60:293-300
19. Sass C, Herbeth B, Siest G, Visvikis S (2000) Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort. J Hypertens 18:1775-1781
20. Sprecher DL, Harris BV, Stein EA, Bellet PS, Keilson LM, Simbartl LA (1996) Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report. Circulation 94:3239-3245
21. Hagberg JM, Ferrell RE, Dengel DR, Wilund KR (1999) Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent. Hypertension 34:18-23
22. Montgomery HE, Clarkson P, Dollery CM et al (1997) Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-747
23. Myerson SG, Montgomery HE, Whittingham M et al (2001) Left ventricular hypertrophy with exercise and the angiotensin converting enzyme gene I/D polymorphism: a randomised controlled trial with losartan. Circulation 103:226-230
24. Brull D, Dhamrait S, Myerson S et al (2001) Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 358:1155-1156
25. Jamshidi Y, Montgomery HE, Hense HW et al (2002) Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105:950-955
26. Finck BN, Kelly DP (2002) Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 34:1249-1257
27. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ (1998) Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18:526-534
28. Day IN, Humphries SE (1994) Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 222:389-395
29. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925
30. Burelle Y, Wambolt RB, Grist M et al (2004) Regular exercise is associated with a protective metabolic phenotype in the rat heart. Am J Physiol Heart Circ Physiol 287:H1055-H1063
31. Ong JM, Simsolo RB, Saghizadeh M, Goers JW, Kern PA (1995) Effects of exercise training and feeding on lipoprotein lipase gene expression in adipose tissue, heart, and skeletal muscle of the rat. Metabolism 44:1596-1605
32. Goodarzi MO, Guo X, Taylor KD et al (2004) Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 53:214-220
33. Kim JK, Fillmore JJ, Chen Y et al (2001) Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98:7522-7527
34. Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S (1998) Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 83:4284-4288
35. Davis CL, Kapuku G, Snieder H, Kumar M, Treiber FA (2002) Insulin resistance syndrome and left ventricular mass in healthy young people. Am J Med Sci 324:72-75
36. Marshall BA, Tordjman K, Host HH et al (1999) Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem 274:27426-27432
37. Holzl B, Iglseder B, Sandhofer A et al (2002) Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency. Diabetologia 45:378-384
38. Garenc C, Perusse L, Bergeron J et al (2001) Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE family study. J Appl Physiol 91:1334-1340
39. Kessler G, Friedman J (1997) Metabolism of fatty acids and glucose. Circulation 98:1351
40. Rupp H, Zarain-Herzberg A, Maisch B (2002) The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz 27:621-636
41. de las Fuentes L, Herrero P, Peterson LR, Kelly DP, Gropler RJ, Davila-Roman VG (2003) Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 41:83-87